Jaquelini Barboza da Silva, MD is a dermatologist in private practice in Santa Cruz do Sul, Brazil. Additionally, Dr. Barboza da Silva is an instructor at Santa Cruz University, where she completed a master’s degree studying biomarkers in psoriasis by spectroscopy. She is a blind investigator in a rizankizumab clinical trial at Moinhos de Vento research center. Dr. Barboza da Silva has scientific interests in biomarkers and the burden of psoriasis. Her key clinical interest is to provide the best treatment for each patient profile. As a 2021 IPC Fellow she is studying with Darren Ashcroft and Chris Griffiths of University of Manchester and attended the 7th Congress of the Skin Inflammation & Psoriasis International Network (SPIN).